Investment Management Corp Of Ontario Alnylam Pharmaceuticals, Inc. Transaction History
Investment Management Corp Of Ontario
- $2.96 Billion
- Q4 2024
A detailed history of Investment Management Corp Of Ontario transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Investment Management Corp Of Ontario holds 7,099 shares of ALNY stock, worth $1.77 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,099
Previous 7,059
0.57%
Holding current value
$1.77 Million
Previous $1.94 Million
13.96%
% of portfolio
0.06%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ALNY
# of Institutions
666Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.15 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.18 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.39 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.74 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.1 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...